Del Laboratories

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Del Laboratories - overview

Established

1961

Location

Uniondale, NY, US

Primary Industry

Consumer Products

About

Del Laboratories is a domain name provider specializing in unique acquisition solutions for online presence, primarily offering the domain dellabs. com for sale or lease. Del Laboratories, established in 1961 and headquartered in Uniondale, US, focuses on the domain name industry. The company has undergone significant changes, including being acquired by Coty in December 2007.


The most recent funding round was a BUYOUT totaling USD 465. 00 mn, with investors including Church & Dwight Co. , Inc. and Kelso & Company.


Since its inception, Del Laboratories has executed 2 deals with a total amount raised of USD 465. 00 mn. Del Laboratories specializes in the sale and lease of domain names, offering unique domain acquisition solutions to businesses and individuals. Their primary product is the domain name dellabs.


com, available for a direct purchase price of USD 19,888 or via a Lease to Own option priced at USD 1,658 per month. The company ensures secure transactions, catering to entrepreneurs and businesses looking for memorable domain names to enhance their online presence. In the most recent year, Del Laboratories reported a revenue of USD 386,000,000. Revenue generation primarily stems from the sale and leasing of the domain name dellabs.


com, with clients enjoying a transparent pricing model and secure payment options. Del Laboratories plans to expand its market presence by exploring new geographical regions, with specific targets for expansion not yet disclosed. The recent BUYOUT funding will be utilized to enhance their product offerings and improve customer experience. The company aims to design and launch new domain acquisition solutions, although specific details on upcoming products or release dates have not been provided.


Primary Industry

Consumer Products

Sub Industries

Beauty & Hygiene, Pharmaceuticals, Commodity Chemicals

Website

www.dellabs.com

Verticals

Manufacturing

Company Stage

Acquired

Total Amount Raised

Subscriber access only

Del Laboratories - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Trade SaleCompletedDel Laboratories-
BuyoutCompletedDel Laboratories-

Displaying 1 - 2 of 2

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.